Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours
- DOI
- 10.15252/emmm.202114501
- Published
- 02
- Container
- EMBO Molecular Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15252/emmm.202114501,
title = {Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours},
author = {Florian J Groelly and Manuela Porru and Jutta Zimmer and Hugo Benainous and Yanti De Visser and Anastasiya A Kosova and Serena Di Vito and Violeta Serra and Anderson Ryan and Carlo Leonetti and Alejandra Bruna and Annamaria Biroccio and Madalena Tarsounas},
year = {2022},
journal = {EMBO Molecular Medicine},
doi = {10.15252/emmm.202114501},
url = {https://doi.org/10.15252/emmm.202114501}
}RIS
TY - JOUR TI - Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours AU - Florian J Groelly AU - Manuela Porru AU - Jutta Zimmer AU - Hugo Benainous AU - Yanti De Visser AU - Anastasiya A Kosova AU - Serena Di Vito AU - Violeta Serra AU - Anderson Ryan AU - Carlo Leonetti AU - Alejandra Bruna AU - Annamaria Biroccio AU - Madalena Tarsounas PY - 2022 JO - EMBO Molecular Medicine DO - 10.15252/emmm.202114501 UR - https://doi.org/10.15252/emmm.202114501 ER -
APA
Groelly, F. J., Porru, M., Zimmer, J., Benainous, H., Visser, Y. D., Kosova, A. A., Vito, S. D., Serra, V., Ryan, A., Leonetti, C., Bruna, A., Biroccio, A., & Tarsounas, M. (2022). Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202114501
Source records
- doaj · retrieved 2026-09-27T02:12:43.595Z